Anna K. Schmidtner
Papers
2
Total Citations
16
H-Index
2
About
Anna K. Schmidtner is a researcher whose work has made meaningful contributions to molecular diagnostics and genomic surveillance, particularly in the context of infectious disease detection. She is best known for her innovative work developing high-throughput SARS-CoV-2 testing methodologies during the COVID-19 pandemic, a period of urgent global need for scalable and efficient diagnostic solutions. Schmidtner's most notable contributions center on reimagining the conventional RT-qPCR testing pipeline. Her 2021 paper on early sample tagging and pooling—garnering 11 citations—demonstrated that simultaneous viral detection and variant sequencing could be achieved within a single streamlined workflow, a significant advance over standard single-purpose diagnostic approaches. Complementing this, her earlier 2020 work introducing ApharSeq, an extraction-free early-pooling protocol with 5 citations, addressed critical bottlenecks in mass testing by eliminating the RNA extraction step, dramatically improving scalability and reducing resource demands. Together, these contributions reflect Schmidtner's focus on making genomic diagnostics faster, more cost-effective, and deployable at population scale. Her research is particularly relevant to students and scientists working at the intersection of molecular biology, public health genomics, and pandemic preparedness—fields where innovative protocol design can have immediate and far-reaching real-world impact.
Research Focus
Key Achievements
Top Papers
- 1
- 2